title: Analysis of cytodiagnostic urinalysis findings in 77 patients with concurrent renal biopsies.
abstract: We investigated the value of cytodiagnostic urinalysis in detecting and scoring the severity of the four types of renal lesions (glomerular, interstitial, tubular, and vascular). Both cytodiagnostic urinalysis and concurrent renal biopsy were performed in 77 patients (47 from native kidneys and 30 from transplants) and the scoring and findings assessed in a double-blinded fashion. Evaluation of the reproducibility for the counting of renal cells showed a low intraobserver and interobserver variation. Cytodiagnostic urinalysis correlated with the renal biopsy with respect to primary lesions in 42 (89%) of the native kidney cases, and in 23 (77%) of the transplant kidney cases. The accuracy of diagnosis of glomerular lesions in both native and transplanted kidneys was 0.91, and for acute rejection in transplanted kidneys, the accuracy of diagnosis was 0.73. Severity scores showed good correlation between cytodiagnostic urinalysis and renal biopsy in both transplanted and in native kidneys and cytodiagnostic urinalysis correlated well with the increase in creatinine levels. The most important components of cytodiagnostic urinalysis for the diagnosis of glomerular lesions were dysmorphic erythrocytes and proteinuria. The specificity and sensitivity of dysmorphic erythrocytes for a glomerular lesion were 0.89 and 0.88, respectively. In cases with biopsy-proven glomerular lesions, more severe changes were found by cytodiagnostic urinalysis when the biopsy showed proliferative lesions in the glomeruli than when normal glomeruli were found by light microscopy. Cytodiagnostic urinalysis has the advantage over renal biopsy that it can be repeated as often as necessary and thus allows observation of the development or regression of the renal lesion over time. We conclude that cytodiagnostic urinalysis is well correlated with the renal biopsy and that it provides valuable and quantitative information regarding the disease process in the kidney.
authors.affiliation: Department of Pathology, University of Alberta Hospital, Edmonton, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Marcussen
authors.forename: J L
authors.initials: JL
authors.lastname: Schumann
authors.forename: G B
authors.initials: GB
authors.lastname: Schumann
authors.forename: M
authors.initials: M
authors.lastname: Parmar
authors.forename: C
authors.initials: C
authors.lastname: Kjellstrand
mesh_terms: D000328:Adult; D001706:Biopsy; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D003581:Cytodiagnosis; D004913:Erythrocytes, Abnormal / Q000473:pathology; D005260:Female; D006084:Graft Rejection / Q000473:pathology; D006418:Heme; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000473:pathology*; D007674:Kidney Diseases / Q000097:blood / Q000473:pathology / Q000652:urine; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D009336:Necrosis; D009504:Neutrophils / Q000473:pathology; D011507:Proteinuria / Q000652:urine; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014556:Urine / Q000166:cytology*
chemical_list: D006418:Heme; D003404:Creatinine